INTRODUCTION
Ayurveda Acharyas have mentioned a set of Garbhavyapads (fetal growth disorders) such as Upavishtaka, Nagodara, Upashushka [1] etc. which describes disorders related to fetal growth. However, these conditions have been mentioned just after Sanjatasara of the Garbha (after attaining stability of the fetus), i.e., during 4 th -5 th month. Growth restrictions in the later period can be considered as Garbha Kshaya.
Garbha Kshaya as stated in the Dosha-Dhatu-MalaKshaya-Vriddhi Vijnaniya Adhyaya of Susrutha Samhita, wherein Sarva Angavayava Sampurnata (conspiracy of all fetal parts) has already taken place. The growth restriction in-utero is evaluated with the Anunnata Kukshi where the fundal height is less than the period of gestation which is the salient feature of Garbha Kshaya.
[2] Besides this, Garbha Aspandana or Ksheena Spandana as per Dalhana is also mentioned as a feature which could be considered as the reduced fetal activity mainly due to the reduced amniotic fluid. Ayurveda describes a definite classical reference for the efficient management of Garbha Kshaya. Acharya Susrutha has mentioned the usage of Ksheera Basti (medicated milk enema) and Medhya (nootropic) drugs from 8 th month onwards to nourish the growth retarded fetus.
Ksheera (milk) is the main element of Garbhini Ahara (maternal diet) having all the qualities to nourish both the mother and the fetus. It is considered as the best Rasayana (rejuvenator and immunomodulator) and is said to be Aajanma Satmya (wholesome throughout
A B S T R A C T
Garbha Kshaya comprising of (Anunnata Kukshi) fundal height less than the period of gestation and (Garbha Aspandana) reduced fetal movement due to reduced amniotic fluid can be taken as fetal growth related disorder mainly IUGR (Intrauterine growth restriction Anal orifice and tip of the catheter were lubricated with the oil. The tip of catheter is inserted into anal canal of the patient steadily and slowly until it reaches inside up to 3-4 inches. Thereafter, the catheter was held slightly upward position above the anal orifice and the administration of Basti was done slowly without shaking the hand, leaving behind a little quantity of Basti drug in the enema can. During the administration of Basti, the patient were instructed to take deep breaths. After the administration of Basti, the catheter was removed from anal canal, and lower back and buttocks was patted (Sphiktadana) 3-4 times. After administration of Basti, patient was asked to turn into supine position and rest on the table till she feels the urge for defecation.
RESULT Case 1:
There was remarkable improvement in the fetal movements from the day 1 of the administration of Basti. There was also increase in the fetal growth parameters and liquor. The patient continued the pregnancy till term and delivered a healthy female baby on 4/10/16 with the birth weight of 2.6kg.
Case 2: Pain in abdomen was relieved and AFI was raised from 5.5cm to 6.5cm. The patient continued ANC checkups and delivered a healthy male baby on 8/9/17 with 3.1 kg birth weight. 
CONCLUSION
Shatavaryadi Ksheerapaka drugs act as Dhatu Vardhana by constructive metabolism and thus have a definite action on fetal growth related disorders. It also improves the amniotic fluid, fetal growth, maternal well being and relives fatigue, constipation, body ache etc. Therefore the present case series focusing to use Shatavaryadi Ksheerapaka Basti, hoping that these drugs will be more effective in counteracting IUGR with its anabolic properties without any side effects. This study also throws light on the future scope of management of IUGR in Ayurvedic obstetrics practice.
